Marc Lohrmann

Marc Lohrmann is Managing Partner at Vesalius Biocapital III. He has over 20 years of experience and joined Vesalius Biocapital in 2012 as a venture partner and became a Managing Partner in 2017. Marc co-founded Reverse Medical (acquired by Covidien in 2014), was an investment manager at Bayer Innovation and worked with several corporate finance boutique firms focused on M&A transactions in the life sciences space. He holds a diploma degree in Business Administration of the University of Stuttgart-Hohenheim.